Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BD acquires Accuri Cytometers

This article was originally published in Clinica

Executive Summary

Becton Dickinson has acquired personal flow cytometer developer Accuri Cytometers for an undisclosed sum. Flow cytometry is used to count and examine microscopic particles such as cells and chromosomes, and can be used to help diagnose disorders such as cancers, as well as having applications in other fields including molecular biology and immunology. Accuri (Ann Arbor, Michigan) markets the C6 system, designed to be portable and affordable, but with the capabilities of a conventional flow cytometer. The acquisition will expand Franklin Lakes, New Jersey-based BD's presence in the affordable personal flow cytometer segment, and the firm believes it will make the technique more accessible to a wider range of scientists and clinicians. The financial impact of the buy has already been incorporated into BD's 2011 financial guidance: in February, the firm predicted that revenues will increase by about 4% over fiscal 2010, and it expects earnings of $5.45-5.55 per share, representing an 11-13% year-on-year increase.

You may also be interested in...

What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts